To further elucidate the mechanism of TRIM17 in osteosarcoma progression, RNA-Seq analysis was performed on the TRIM17 knockdown group and the control group, revealing that TRIM17 primarily regulates the AKT/mTOR signaling pathway. This evidence concerns the gene AKT1 and osteosarcoma.